578
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Determinants of Opportunistic Infections Among HIV-Positive Patients on HAART in Debre Berhan Referral Hospital, North Shoa Zone, Ethiopia, 2020: A Case–Control Study

ORCID Icon, , ORCID Icon & ORCID Icon
Pages 337-347 | Published online: 29 Mar 2021

References

  • Kasper F. Harrison’s Principles of Internal Medicine. 19th ed. New York: The McGraw-Hill Companies, Inc.; 2015.
  • Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the. Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed March 23, 2021.
  • Ethiopian Public Health Institute and ICAP at Columbia University, Ethiopia Population-Based HIV Impact Assessment (EPHIA) 2017–2018. Summary Sheet: Preliminary Findings; April, 2018:4–7.
  • Urgessa F, Ararsa A, Ataro Z. Prevalence and associated risk factors of opportunistic infections among anti-retro viral treatment naive HIV/AIDS infected patients. J AIDS Clin Res. 2018;09(03). doi:10.4172/2155-6113.1000763
  • Ethiopian Public Health Institute. HIV related estimates and projections for Ethiopia. Ethiopian Public Health Institute; March, 2017.
  • Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort (Reprinted from Annals of Internal Medicine, vol 124, pg 633–642, 1996). Formulary. 1997;32:S32–42. doi:10.7326/0003-4819-124-7-199604010-00003
  • Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. Clin Infect Dis. 2005;40(Supplement_3):S131–235.
  • CDC - Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report – guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children; 2009:58.
  • Ethiopia Federal HIV/AIDS Prevention and Control Office. Guidelines for management of opportunistic infections and anti-retroviral treatment in adolescents and adults in Ethiopia, March 2008; March, 2008:1–109.
  • Federal Ministry of Health. National guidelines for comprehensive HIV prevention, care and treatment; 2017:44–46.
  • Federal HIV/AIDS Prevention and Control Office. HIV prevention in Ethiopia: National Road Map; November, 2018:1–43.
  • Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. MMWR Mob Mortal Weekly Recommit Rep. 2005;53(RR–15):1–112.
  • Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus–associated opportunistic infections in the United States in the Era of highly active antiretroviral therapy. Clin Infect Dis. 2000;30(s1):S5–14. doi:10.1086/313843
  • Hamza OJM, Matee MIN, Simon ENM, et al. Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health. 2006;6(1):1–9. doi:10.1186/1472-6831-6-12
  • Khongkunthian P, Grote M, Isaratanan W, Piyaworawong S, Reichart PA. Oral manifestations in 45 HIV-positive children from Northern Thailand. J Oral Pathol Med. 2001;30(9):549–552. doi:10.1034/j.1600-0714.2001.300907.x
  • Gona P, Williams PL, Chernoff MC, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. J Am Med Assoc. 2006;296(3):292–300. doi:10.1001/jama.296.3.292
  • Mitiku H, Weldegebreal F, Teklemariam Z. Magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in eastern ethiopia. HIV/AIDS Res Palliat Care. 2015;7:137–144. doi:10.2147/HIV.S79545
  • Mitiku AA, Dessie ZG, Muluneh EK, Workie DL. Prevalence and associated factors of TB/HIV co-infection among HIV Infected patients in Amhara region, Ethiopia. Afri Health Sci. 2016;16(2):588–595. doi:10.4314/ahs.v16i2.29
  • Damtie D, Yismaw G, Woldeyohannes D, Anagaw B. Common opportunistic infections and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia. BMC Res Notes. 2013;6(1). doi:10.1186/1756-0500-6-534
  • Solomon FB, Angore BN, Koyra HC, Tufa EG, Berheto TM, Admasu M. Spectrum of opportunistic infections and associated factors among people living with HIV/AIDS in the era of highly active anti-retroviral treatment in Dawro Zone hospital: a retrospective study. BMC Res Notes. 2018;11(1):1–7. doi:10.1186/s13104-018-3707-9
  • Kibret KT, Yalew AW, Belaineh BG, Asres MM. Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a Case Control Study. PLoS One. 2013;8(5):23–27. doi:10.1371/journal.pone.0064488
  • Mohammed T, Taha M, Deribew A, Tessema F, Assegid S, Colebunders R. Risk factors of active tuberculosis in people living with HIV/AIDS in Southwest Ethiopia. Ethiop J Health Sci. 2009;21(2):131–139. doi:10.4314/ejhs.v21i2.69053
  • Wu ES, Metzger DS, Lynch KG, et al. Association between alcohol use and HIV viral load. J Acquir Immune Defic Syndr. 1999;56.5(2011):e129. doi:10.1097/QAI.0b013e31820dc1c8
  • Moges NA, Kassa GM. Prevalence of opportunistic infections and associated factors among HIV positive patients taking anti-retroviral therapy in Debre Markos referral hospital, northwest Ethiopia. J AIDS Clin Res. 2014;5(5). doi:10.4172/2155-6113.1000301
  • World Medical Association. World Medical Association declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79(4):373–374. World Health Organization.